From NHS-Academic-NHS Clinical Entrepreneur Programme Mentor Sola Adeleke CoFounder Curenetics to his NHS-Honorary Academic-NHS Clinical Entrepreneur Programme Mentee CoFounder OncoFlow

Curenetics, Queen Mary University London (QMUL), Oracle Cancer Trust and South East Health Technologies Alliance (SEHTA) are working collaboratively to pioneer a transformative approach to oral cancer detection through the Novel AI-Enabled qMIDS Test. The research is funded by the National Institute for Health and Care Research (NIHR), the research partner of the NHS, public health and social care.

Following MedCity’s Collaborate to Innovate Speed networking event held on 25 April 2022, Curenetics – an innovative AI Diagnostics company – and Prof Yong-Jie Lu – a leading expert in molecular oncology – and his team at Queen Mary University of London (QMUL) signed a Confidential Disclosure Agreement (CDA).

If starting his own business wasn’t achievement enough, Sola Adeleke's business Curenetics has the potential to improve cancer patient's prognosis, and their quality of life AND save the NHS millions

Sola Adeleke, the founder of Curenetics reflects on the top three things he wishes he’d known prior to starting his business Curenetics in 2018.

Our CEO Sola Adeleke recently attended Cardiff University for the Learn2Innovate Student Healthcare Innovation Programme as the Cross University Collaborative innovation task group Mentor.

Our Founder and CEO, Dr. Sola Adeleke, at the House of Parliament Roundtable sharing his thoughts on the success of UK Biobank. Sola expresses the need for further access to data for innovative spinouts.

As the part of the innovative digital Healthcare organisation, we were delighted to attend this great event organised by the Health Foundry discussing various ideas and innovations with this diverse talents in MedTech.

Description goes An innovative healthcare start-up is re-evaluating how patients, recruiters and other healthcare organisations access clinical trials. Over 9 weeks, Brunel University London Design students designed a variety of concepts for Curenetics new clinical trials app

Earlier this week we were delighted to announce the launch of nine match-funded research projects made possible through MedCity’s Collaborate to Innovate: London Diagnostics programme. Now at the beginning of their 12-month journey, each project team will work to develop diagnostics tools and technologies capable of transforming outcomes for diseases adversely impacting diverse patient populations. Here we introduce each project, the partners involved, and their objectives.

Nine London-based diagnostic healthcare SMEs developing screening tests and technologies to detect some of the UK’s most debilitating diseases, have been awarded match-funded research partnerships with experts in academia and industry.